Almonertinib mesylate is an irreversible, highly selective EGFR tyrosine kinase inhibitor targeting sensitizing and T790M resistance mutations. It is widely used in non-small cell lung cancer (NSCLC) research, with applications in both in vitro biochemical assays and in vivo xenograft models to study efficacy and resistance mechanisms.
Molekulargewicht:
621.75
Reinheit:
99.92% (May vary between batches)
CAS Nummer:
[2134096-06-1]
Formel:
C31H39N7O5S
Target-Kategorie:
EGFR
Anwendungsbeschreibung:
Solubility: DMSO:40 mg/mL (64.33 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten